Professional Documents
Culture Documents
PSM w bonus
PSM w bonus
PSM w bonus
14
CHAPTER
PSM BTR by Dr. Zainab Vora
238
BTR by Dr. Zainab Vora PSM
239
PSM BTR by Dr. Zainab Vora
240
BTR by Dr. Zainab Vora PSM
241
PSM BTR by Dr. Zainab Vora
242
BTR by Dr. Zainab Vora PSM
243
PSM BTR by Dr. Zainab Vora
244
BTR by Dr. Zainab Vora PSM
245
PSM BTR by Dr. Zainab Vora
246
BTR by Dr. Zainab Vora PSM
247
PSM BTR by Dr. Zainab Vora
248
BTR by Dr. Zainab Vora PSM
249
PSM BTR by Dr. Zainab Vora
250
BTR by Dr. Zainab Vora PSM
251
PSM BTR by Dr. Zainab Vora
252
BTR by Dr. Zainab Vora PSM
253
PSM BTR by Dr. Zainab Vora
254
BTR by Dr. Zainab Vora PSM
255
PSM BTR by Dr. Zainab Vora
256
BTR by Dr. Zainab Vora PSM
257
PSM BTR by Dr. Zainab Vora
258
BTR by Dr. Zainab Vora PSM
259
PSM BTR by Dr. Zainab Vora
260
BTR by Dr. Zainab Vora PSM
261
PSM BTR by Dr. Zainab Vora
262
BTR by Dr. Zainab Vora PSM
263
PSM BTR by Dr. Zainab Vora
264
PSM
BONUS-BTR
Health care delivery in India
Hilly/tribal Plains Staff Beds
1 doctor/ 1000
Sub-centre 1 nurse/5000 population
(HWC) 1 lab tech /10k
A- 1 pharmacist /10k
B- 1 malaria microscope/ 25k
1 SET / 25k
PHC 1 TB microscope/ 1 lakh
A- 1 TB unit/ 5 lakh
B- 1 STLS /5 lakh
School health 1 ophthalmologist/5 lakh population or 5 CHC
U-PHC
CHC
U-CHC
Metro:
Health care delivery in India
ASHA AWW TBA VHG MPW (m) MPW (F)= HA/HV USHA
ANM
Impact indicator:
Health management
Network analysis
•
NTEP saved Rupees 1000 cr
•
NTEP saved 1 lakh lives/ QALY gained
•
CBNAAT versus sputum in terms of cost
• Input-output analysis
Program Management and Review Critical Path Method
Technique (PERT)
Communicable disease
Source: Transmits IP COMMUNIC IMPORTANT
Reservoir: Natural habitat ABLE
PERIOD
Host-Recipient VARICELLA Centrifugal, MC complication:
Primary-Sexual cycle VZIG:
Secondary-Asexual cycle MEASLES MC complication: MCC of mortality:
Malaria-
Hydatid- RUBELLA Seasonal, cyclical trend, Iceberg (?)
Healthy carriers:
DIPHTHERIA Iceberg
Case: Isolation+ Culture/Serum +Antibiotic+ Antitoxin
Rifabutin
Contacts:
DS TB: INH x 6m
Rifapentin+INH x3mon weekly
OPV switch-
P3- Impact indicator: Prevalence <1/10k
Leprosy prophylaxis:
AFP surveillance: >20hrs a week
<15yrs with AFP >2yrs
SMO
2 stool samples 24hrs apart
>8g with reverse cold chain
Reach lab in 72hrs
Residual paralysis check:
Other programs
NIDDCP:
Impact indicator:
Principal impact and epidemiological indicator:
Process indicator:
Cold chain
Day carrier:
Vaccine carrier:
Small ILR:
Without electricity?
Prevalence
Incidence
Attack rate
Ordinal:
External validity:
High-yield
Survey systems: No of live births in an area:100
Eligible Couple:
Target couple: